SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. You have free access to this content1
    Thomas D. Giles, Bobby V. Khan, June Lato, Lillian Brener, Yimin Ma, Tatjana Lukic, Nebivolol Monotherapy in Younger Adults (Younger Than 55 Years) With Hypertension: A Randomized, Placebo-Controlled Trial, The Journal of Clinical Hypertension, 2013, 15, 9
  2. 2
    Robert J. Weiss, Manfred Stapff, Yuhua Lin, Placebo Effect and Efficacy of Nebivolol in Patients with Hypertension not Controlled with Lisinopril or Losartan: A Phase IV, Randomized, Placebo-Controlled Trial, American Journal of Cardiovascular Drugs, 2013, 13, 2, 129

    CrossRef

  3. 3
    Andrew Lewin, Kenneth C. Lasseter, Fang Dong, John C. Whalen, Nebivolol withdrawal results in blood pressure returning toward pretreatment levels, but without rebound symptoms: phase IV randomized trial, Journal of the American Society of Hypertension, 2012, 6, 3, 228

    CrossRef

  4. 4
    Charles Lindamood, Stephan Ortiz, Andrew Shaw, Russ Rackley, J. Christopher Gorski, Effects of Commonly Administered Agents and Genetics on Nebivolol Pharmacokinetics: Drug-Drug Interaction Studies, The Journal of Clinical Pharmacology, 2011, 51, 4
  5. 5
    Robert J. Weiss, Elijah Saunders, Mark Greathouse, Efficacy and Tolerability of Nebivolol in Stage I–II Hypertension: A Pooled Analysis of Data From Three Randomized, Placebo-Controlled Monotherapy Trials, Clinical Therapeutics, 2011, 33, 9, 1150

    CrossRef

  6. You have free access to this content6
    William H. Frishman, Elijah Saunders, β-Adrenergic Blockers, The Journal of Clinical Hypertension, 2011, 13, 9
  7. 7
    J M Neutel, D H G Smith, A H Gradman, Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage I–II hypertension, Journal of Human Hypertension, 2010, 24, 1, 64

    CrossRef

  8. 8
    Javier Angulo, Harold M. Wright, Pedro Cuevas, Rocío González-Corrochano, Argentina Fernández, Begoña Cuevas, José M. La Fuente, Sandeep Gupta, Iñigo Sáenz de Tejada, Nebivolol Dilates Human Penile Arteries and Reverses Erectile Dysfunction in Diabetic Rats through Enhancement of Nitric Oxide Signaling, The Journal of Sexual Medicine, 2010, 7, 8
  9. You have free access to this content9
    Mark Greathouse, Nebivolol Efficacy and Safety in Patients with Stage I-II Hypertension, Clinical Cardiology, 2010, 33, 4
  10. 10
    Jan N. Basile, One Size Does Not Fit All: The Role of Vasodilating β-Blockers in Controlling Hypertension as a Means of Reducing Cardiovascular and Stroke Risk, The American Journal of Medicine, 2010, 123, 7, S9

    CrossRef

  11. 11
    George L. Bakris, Jan N. Basile, Thomas D. Giles, Addison A. Taylor, The Role of Nitric Oxide in Improving Endothelial Function and Cardiovascular Health: Focus on Nebivolol, The American Journal of Medicine, 2010, 123, 7, S2

    CrossRef

  12. 12
    Thomas D. Giles, The Role of Vasodilating β-Blockers in Patients with Complicated Hypertension: Focus on Nebivolol, The American Journal of Medicine, 2010, 123, 7, S16

    CrossRef

  13. 13
    Vasilios Papademetriou, Comparison of Nebivolol Monotherapy Versus Nebivolol in Combination With Other Antihypertensive Therapies for the Treatment of Hypertension, The American Journal of Cardiology, 2009, 103, 2, 273

    CrossRef

  14. 14
    F. Wilford Germino, Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: A retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension, Clinical Therapeutics, 2009, 31, 9, 1946

    CrossRef

  15. 15
    Claudine M. Baldwin, Susan J. Keam, Nebivolol, American Journal Cardiovascular Drugs, 2009, 9, 4, 253

    CrossRef

  16. 16
    James H. O'Keefe, Maia D. Carter, Carl J. Lavie, Primary and Secondary Prevention of Cardiovascular Diseases: A Practical Evidence-Based Approach, Mayo Clinic Proceedings, 2009, 84, 8, 741

    CrossRef

  17. You have free access to this content17
    Camila Manrique, Thomas D. Giles, Keith C. Ferdinand, James R. Sowers, Realities of Newer β-Blockers for the Management of Hypertension, The Journal of Clinical Hypertension, 2009, 11, 7
  18. 18
    Michala E Pedersen, John R Cockcroft, What is the role, if any, for beta-blockers as initial therapy for uncomplicated hypertension?, Current Opinion in Cardiology, 2009, 24, 4, 325

    CrossRef

  19. 19
    Thomas D Giles, Continuing evolution of the role of β-blockers in the treatment of hypertension, Therapy, 2008, 5, 6, 773

    CrossRef

  20. 20
    Sandeep Gupta, Harold M. Wright, Nebivolol: A Highly Selective β1-Adrenergic Receptor Blocker That Causes Vasodilation by Increasing Nitric Oxide, Cardiovascular Therapeutics, 2008, 26, 3
  21. 21
    David Wojciechowski, Vasilios Papademetriou, β-blockers in the management of hypertension: focus on nebivolol, Expert Review of Cardiovascular Therapy, 2008, 6, 4, 471

    CrossRef

  22. You have free access to this content22
    Michael A. Weber, George L. Bakris, Thomas D. Giles, Franz H. Messerli, β-Blockers in the Treatment of Hypertension: New Data, New Directions, The Journal of Clinical Hypertension, 2008, 10, 3